2Kantarjian HM, Talpaz M, Smith T, et al. Homoharringtonine and low-dose cytarabine in the management of late chronic-phase chronic myelogenans leukemia [ J ]. J Clin Oncol, 2000, 18 ( 20 ) : 3513 -3521.
3Luo CY, Tang JY, Wang YP. Homoharringtonine a new treatment option for myeloid leukemia [ J ]. Hematology, 2004,9 (4) : 259 - 270.
4Quintas-Cardama A, Cortes J. Homoharringtonine for the treatment of chronic myelogenous leukemia [ J ]. Expert Opin Pharmacother, 2008,9(6) :1029 - 1037.
5Quintas-Cardama A, Kantarjian H, Garcia MG, et al. Phase I / II study of subcutaneous homoharringtonine in patients with chronic myeloid leukemia who have failed prior therapy[ J ]. Cancer,2007, 109(2) :248 -255.
6Iyer L,Ratain M J.Clinical pharmacology of camptothecins[J].Cancer Chemother Pharmacol,1998,42(Suppl):S31-43.
